Dubai Final-v20.indd - World Allergy Organization

More documents

Recommendations

Info

WElCOmE lEttErs ruby Pawankar President Elect, WAO Conference Organizing Chair WAO IntErnAtIOnAl ScIEntIfIc cOnfErEncE Asthma and Co-morbid Conditions: Expanding the Practice of Allergy for Optimal Patient Care Dear Colleagues, Welcome to Dubai and the World Allergy Organization’s 1st international scientific Conference! the theme of this Conference, “Asthma and Co-morbid Conditions: Expanding the Practice of Allergy for Optimal Patient Care,” is one that, as President of the WAO, i have promised to promote through research and education. As a member of the worldwide specialty of allergy, asthma and clinical immunology, i would like to encourage a culture in which allergists/immunologists are first knowledgeable primary care physicians, internists, and pediatricians, and then specialists. Physicians trained in this way should be able to provide patients with more complete, cost-effective care for asthma and allied allergic and immunologic diseases. they should be able to diagnose and treat co-morbid conditions. thus, the theme of this Conference is to capture and reflect this vision. Your participation in this inaugural event will help transform this vision of how we manage allergic diseases into everyday practice. i wish you a most successful Conference. richard F. lockey President, World Allergy Organization (WAO) On behalf of the WAO Board of Directors Dear Friends, We join richard lockey in warmly welcoming you to this meeting. it has been a most rewarding experience organizing this Conference and developing its scientific program. We are confident that as a participant your experience will be equally energizing for you. the scientific and educational program is designed to provide a forum for the latest research, reviews of current theory and practice, and importantly, “hands-on” problem-based learning. it is our hope, that as practitioners, educators, and researchers, you will take away from this Conference valuable insight into the most effective advances in the diagnosis and management of asthma and its comorbidities as well as broader aspects of related allergic disorders to meet the challenges of the global unmet needs in this area. We want to take this opportunity also to thank the exceptionally skilled and committed faculty who are a truly international and versatile group. A majority of the faculty is presenting more than once covering different session-types and several co-morbidities – demonstrating in this range the true meaning of the theme of this Conference: “Asthma and Co-morbid Conditions: Expanding the Practice of Allergy for Optimal Patient Care”. An equally important part of learning occurs outside the sessions when we have the important opportunity to meet up with colleagues to exchange ideas, make new connections and continue old conversations. We hope you will do plenty of all this. Please share with us your feedback and ideas so that we can continue to promote excellence in the field of allergy and asthma. Once again: Welcome! sincerely, g. Walter Canonica Past President, WAO Executive Chair, scientific Program Committee Eric Bateman Co-Chair, scientific Program Committee Stephen T. Holgate member-at-large, WAO Board Co-Chair, scientific Program Committee robert lemanske Co-Chair, scientific Program Committee www.worldallergy.org 2 FinAl PrOgrAm
WAO IntErnAtIOnAl ScIEntIfIc cOnfErEncE Asthma and Co-morbid Conditions: Expanding the Practice of Allergy for Optimal Patient Care On behalf of the Dubai Health Authority, i would like to welcome you to the World Allergy Organisation’s (WAO’s) inaugural international scientific Conference that is taking place in Dubai from the 5th to the 8th of December, 2010 at the Dubai international Convention and Exhibition Centre As a strategic and principle health authority for the Emirate of Dubai, the DHA is responsible for securing and policing the very best healthcare standards in Dubai and is also responsible for developing the future direction of health policy here in Dubai. Hosting, attending and speaking at congresses such as this are an important part of our vision as we continue to develop healthcare policies that meet the requirements of our population, now and in the future. the Conference programme highlights a range of issues and areas of interests that will be explored over the next few days. this is reflected in the number of eminent healthcare professionals from around the world who will be joining and speaking at the Conference. this is a platform where international and local eminent speakers will get an opportunity to discuss and understand the latest in the diagnosis and management of asthma and its co-morbidities. the forum shall help healthcare professionals interact with colleagues, regional leaders and world experts in the field, thus updating their knowledge. With this, i wish you all the best and i hope you enjoy the Conference. His Excellency Qadhi saeed Al murooshid Director general of the Dubai Health Authority www.worldallergy.org 3 FinAl PrOgrAm
Page 1 and 2: Final Program 5-8 December 2010 •
Page 3: CO COImportant Dates 30 June 2011 E
Page 7 and 8: ABOUt WAO the World Allergy Organiz
Page 9: WAO mEmBEr sOCiEtiEs Albanian socie
Page 12 and 13: gEnErAl inFOrmAtiOn, A-Z BAnKs/Atm
Page 14 and 15: ONBREZ ® BREEZHALER ® Important n
Page 16 and 17: COnFErEnCE inFOrmAtiOn, A-Z DisClAi
Page 18 and 19: COnFErEnCE inFOrmAtiOn, A-Z sPEAKEr
Page 20 and 21: Helping to control asthma throughou
Page 22 and 23: OPtiOnAl tOUrs CitY OF COntrAsts -
Page 24 and 25: EXHiBitiOn FlOOrPlAn sHEiKH rAsHiD
Page 26 and 27: EXHiBitOr DirECtOrY EaaCi - Europea
Page 28: EXHiBitOr DirECtOrY omron Healthcar
Page 32 and 33: WAO IntErnAtIOnAl ScIEntIfIc cOnfEr
Page 34 and 35: PrOgrAm-At-A-glAnCE registration Ou
Page 36 and 37: sUnDAY, 5 DECEmBEr 2010 WAO IntErnA
Page 38 and 39: sUnDAY, 5 DECEmBEr 2010 WAO IntErnA
Page 40 and 41: mOnDAY, 6 DECEmBEr 2010 WAO IntErnA
Page 46 and 47: tUEsDAY, 7 DECEmBEr 2010 WAO IntErn
Page 52 and 53: WEDnEsDAY, 8 DECEmBEr 2010 WAO IntE
Page 54 and 55:
WEDnEsDAY, 8 DECEmBEr 2010 WAO IntE
Page 56 and 57:
POstErs POstErs WAO IntErnAtIOnAl S
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78:
Page 81 and 82:
ABstrACts results: the prevalence o
Page 83 and 84:
ABstrACts effective diagnosis and e
Page 85 and 86:
ABstrACts mWCnts on OVA-asthma mode
Page 87 and 88:
ABstrACts allergy in human. A Burka
Page 89 and 90:
ABstrACts Patients with all negativ
Page 91 and 92:
ABstrACts both gender, suggesting a
Page 93 and 94:
ABstrACts 1208 THE rolE oF inTErlEU
Page 95 and 96:
ABstrACts of oral steroids in last
Page 97 and 98:
ABstrACts 1215 aSTHma ComPliCaTion
Page 99 and 100:
ABstrACts to allergens, lower sever
Page 101 and 102:
ABstrACts 1301 non-EoSinoPHiliC aST
Page 103 and 104:
ABstrACts participated in this stud
Page 105 and 106:
ABstrACts for attacks of shortness
Page 107 and 108:
ABstrACts blood CD4+ t cells expres
Page 109 and 110:
ABstrACts Conclusion Air pollution
Page 111 and 112:
ABstrACts 1322 EPiTHElial CEll DEri
Page 113 and 114:
ABstrACts 1326 analYSiS oF gEnE EXP
Page 115 and 116:
ABstrACts rhinitis patients in Hosp
Page 117 and 118:
ABstrACts selected adults from the
Page 119 and 120:
ABstrACts nasal Olopatadine led to
Page 121 and 122:
ABstrACts therapy. However, patient
Page 123 and 124:
ABstrACts that when Ds within the s
Page 125 and 126:
ABstrACts result the patient was di
Page 127 and 128:
ABstrACts 2203 FooD allErgY anD aTo
Page 129 and 130:
ABstrACts 1.11+/- 0.81 for type i a
Page 131 and 132:
ABstrACts 2212 aSSESSing PoTEnTial
Page 133 and 134:
ABstrACts regular treatment with be
Page 135 and 136:
ABstrACts 2301 EFFECT oF a SYnBioTi
Page 137 and 138:
ABstrACts C3 (50 mg/dl; normal 90 -
Page 139 and 140:
ABstrACts introduction : HAE is a g
Page 141 and 142:
ABstrACts PoSTEr SESSion 3-1: immun
Page 143 and 144:
ABstrACts smaller than 100 nm. Cell
Page 145 and 146:
ABstrACts and dry weather city of A
Page 147 and 148:
ABstrACts 3114 igg4 aS THE PrEDomin
Page 149 and 150:
ABstrACts Conclusion: Our study dem
Page 151 and 152:
ABstrACts abscesses are visible at
Page 153 and 154:
ABstrACts allergen release (depot e
Page 155 and 156:
ABstrACts COnClUsiOns: Empiric trea
Page 157 and 158:
ABstrACts Conclusion:sPlAD and FPig
Page 159 and 160:
ABstrACts autumn only in 13% of cas
Page 161 and 162:
ABstrACts mEtHODs: ninety-six child
Page 163 and 164:
ABstrACts 3321 aSSoCiaTion BETWEEn
Page 165 and 166:
sPEAKEr AnD CHAirPErsOn inDEX last
Page 167 and 168:
POstEr AUtHOr inDEX WAO IntErnAtIOn
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
nOtEs WAO IntErnAtIOnAl ScIEntIfIc
Page 175 and 176:
Q411-10 Allergic disease is a growi
Page 177:
2010 WAO IntErnAtIOnAl ScIEntIfIc c
show all

Dubai Final-v20.indd - World Allergy Organization

Create successful ePaper yourself

Delete template?

Save as template?